ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

QGEN Qiagen NV

42.34
-1.01 (-2.33%)
Jun 14 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Qiagen NV QGEN NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
-1.01 -2.33% 42.34 19:00:00
Open Price Low Price High Price Close Price Previous Close
43.16 42.275 43.20 42.34 43.35
more quote information »

Recent News

Date Time Source Heading
6/13/202415:05GLOBEQIAGEN’s software QCI Interpret accelerates clinical..
6/12/202415:05GLOBEQIAGEN publishes 2023 sustainability report, highlighting..
6/11/202415:05GLOBEQIAGEN launches new QIAcuity digital PCR assays for..
6/06/202415:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
6/06/202415:05GLOBEQIAGEN to discontinue NeuMoDx integrated PCR testing system,..
6/05/202415:05GLOBEQIAGEN launches digital PCR Assay Design Tool for QIAcuity,..
6/03/202401:00GLOBEQIAGEN expands QIAstat-Dx syndromic testing menu in the U.S...
5/31/202415:42EDGAR2Form SD - Specialized disclosure report
5/30/202416:55GLOBEQIAGEN and Myriad Genetics develop distributable homologous..
5/30/202415:45EDGAR2Form S-8 - Securities to be offered to employees in employee..
5/30/202415:05GLOBEQIAGEN and Myriad Genetics develop distributable homologous..
5/29/202415:05GLOBEQIAGEN launches new library preparation kit, facilitating..
5/14/202415:05GLOBEQIAGEN receives European IVDR certification for QIAGEN..
5/13/202401:00GLOBEQIAGEN receives FDA clearance for QIAstat-Dx respiratory..
5/07/202415:05GLOBEQIAGEN partners with FBI to develop digital PCR assay for..
5/02/202415:05GLOBEQIAGEN enhances bioinformatics workflows with new secondary..
4/29/202415:05GLOBEQIAGEN reports results for Q1 2024 ahead of outlook, on..
4/24/202415:05GLOBEQIAGEN expands tuberculosis portfolio with new NGS Panel to..
4/09/202408:48GLOBEQIAGEN N.V. to release results for Q1 2024 and hold webcast
4/03/202415:05GLOBEQIAGEN strengthens its portfolio for cancer research,..
3/25/202415:05GLOBEQIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test..
3/18/202415:05GLOBEQIAGEN partners with International Panel Physicians..
3/11/202404:59GLOBEQIAGEN announces Form 20-F annual report filing for 2023..
2/27/202416:44GLOBEQIAGEN launches AI-derived biomedical knowledge base to..
2/27/202415:05GLOBEQIAGEN earns ACT Label for new eco-friendlier QIAwave..
2/15/202415:05GLOBEQIAGEN earns ACT Label for new eco-friendlier QIAwave..
2/08/202408:47EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/06/202415:05GLOBEQIAGEN exceeds outlook for Q4 2023, led by 8% CER sales..
1/25/202409:00GLOBEQIAGEN announces partnership with Penn State University to..
1/23/202415:13EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/18/202415:05GLOBEQIAGEN announces details for completion of synthetic share..
1/11/202406:53GLOBEQIAGEN N.V. to release results for Q4 2023 and hold webcast
1/08/202408:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/08/202401:00GLOBEQIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use..
1/07/202412:07GLOBEQIAGEN announces plans to return approximately $300 million..
1/04/202415:05GLOBEQIAGEN to accelerate investments into QIAGEN Digital..
1/03/202401:00GLOBEQIAGEN expands business in Middle East with new regional..
11/30/202315:05GLOBEDNA Labs International solves significant cold cases with..
11/15/202315:05GLOBEQIAGEN launches TissueLyser III and RNeasy PowerMax Soil Pro..
11/09/202315:05GLOBEQIAGEN launches new QIAcuity digital PCR kits and updated..
11/06/202315:05GLOBEQIAGEN launches complete Sample to Insight workflow for..
11/02/202307:00PRNUSQIAGEN and Element Biosciences partner to offer complete..
10/30/202315:05GLOBEQIAGEN exceeds outlook for Q3 2023 with 5% CER sales growth..
10/26/202307:00GLOBEQIAGEN and Myriad Genetics partner to advance companion..
10/09/202310:14GLOBEQIAGEN N.V. to release results for Q3 2023 and hold webcast
10/04/202315:05GLOBEQIAGEN launches QuantiFERON-EBV RUO assay, facilitating..
9/28/202315:05GLOBEQIAGEN extends AI capabilities of its NGS interpretation..
9/27/202315:05GLOBEQIAGEN reports progress toward achieving Environmental,..
9/25/202315:05GLOBEQIAGEN enhances QIAwave portfolio with new eco-friendlier..
8/25/202315:48EDGAR2Form 144 - Report of proposed sale of securities

Your Recent History

Delayed Upgrade Clock